Cite
HARVARD Citation
Baka‐Ostrowska, M. et al. (2021). Efficacy and safety of mirabegron in children and adolescents with neurogenic detrusor overactivity: An open‐label, phase 3, dose‐titration study. Neurourology and urodynamics. 40 (6), pp. 1490-1499. [Online].